Atole
1 paper3 findings
- 1 lab
- Human trial1
Outcomes
3GrimAge
downin humans1
1 study
GrimAge
downin humans1
Atole decreases GrimAge in humans (-0.85 y, 95% CI -1.53, -0.11).
“and GrimAge acceleration (-0.85 y, 95% CI -1.53, -0.11) compared to other exposures”
Human trialduring first 1,000 days of lifen = 1,095
Early-life nutrition supplementation and epigenetic age in middle-adulthood among Guatemalan adults
bioRxiv : the preprint server for biology29 Sep 2025Preprint
PhenoAge
downin humans1
1 study
PhenoAge
downin humans1
Atole decreases PhenoAge in humans (-1.91 y, 95% CI -3.43, -0.39).
“PhenoAge acceleration (- 1.91 y, 95% CI -3.43, -0.39)”
Human trialduring first 1,000 days of lifen = 1,095
Early-life nutrition supplementation and epigenetic age in middle-adulthood among Guatemalan adults
bioRxiv : the preprint server for biology29 Sep 2025Preprint
DunedinPACE
downin humans1
1 study
DunedinPACE
downin humans1
Atole decreases DunedinPACE in humans (-0.03, 95% CI -0.06, -0.004).
“exposure to atole during any of the first 1,000-day period was associated with lower DunedinPACE (-0.03, 95% CI -0.06, -0.004)”
Human trialduring first 1,000 days of lifen = 1,095
Early-life nutrition supplementation and epigenetic age in middle-adulthood among Guatemalan adults
bioRxiv : the preprint server for biology29 Sep 2025Preprint